The company is substantially advanced the progress of an novel treatment for ATTR-CM, leveraging the investigational drug. Initial clinical information suggests promising improvements for patients suffering with this https://attruby447665.blog2learn.com/89755331/firm-advances-attr-cm-treatment-through-the-therapy